United States Antibiotics market 2025: Industry Developments, Future Growth, Share & Industry Insights | GSK plc, Merck, Wockhardt, Iterum Therapeutics, Aurobindo Pharma Limited, Basile Pharmaceutical

Antibiotics market is reached US$ 41.54Billion in 2024 and is expected to reach US$ 55.26Billion by 2033, growing at a CAGR of 3.20% during the forecast period 2025-2033.

DataM Intelligence has published a new research report on "Antibiotics Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/antibiotics-market?sg

Key Players: Pfizer Inc., GSK plc., Merck & Co., Inc., Johnson & Johnson, Cipla, Lupin, Aurobindo Pharma Limited, Basile Pharmaceutical Ltd., Wockhardt, Iterum Therapeutics plc., AbbVie Inc.

USA - Industry Latest News 2025

✅ Mar 25, 2025 - FDA approval: GSK's Blujepa (gepotidacin) approved for uncomplicated urinary tract infections (women & girls ≥12). GSK planned a US launch in H2 2025.

✅ Feb 07, 2025 - FDA approval: Emblaveo (AbbVie/Pfizer) approved for complicated intra-abdominal infections; commercialization split AbbVie (US/Canada) and Pfizer (other regions).

✅ Jun 10, 2025 - Regulatory milestone: US FDA accepted the NDA for zoliflodacin (first-in-class oral spiropyrimidinetrione for uncomplicated gonorrhoea) if approved this would be the first new oral gonorrhoea antibiotic in decades.

✅ May 21, 2025 - M&A / portfolio build: Paratek completed acquisition of OptiNose, broadening its commercial footprint around its antibiotic NUZYRA and adding new specialty products.

✅ Aug 07, 2025 - M&A (antibiotic assets): Melinta Therapeutics (antibiotic-focused) was acquired by CorMedix in a strategic deal to strengthen commercial portfolio (deal announced/closed in 2025).

Japan - Industry Latest News 2025

✅ Apr 02, 2025 - Licensing: Shionogi signed licensing arrangements/partnerships to expand commercialization of anti-infectives (examples: regional licensing deals for cefiderocol and ongoing clinical data presentations).

✅ Aug 18, 2025 - Policy/funding: Japan's Ministry of Health (MHLW) announced additional funding to GARDP to accelerate R&D for drug-resistant infections (support covering April 2025-March 2026). This is a notable national-level commitment to AMR R&D.

South Korea - Industry Latest News 2025

✅ Feb 28, 2025 - Approval / Launch: Fetroja (cefiderocol) received approval in South Korea as a treatment option for infections caused by multidrug-resistant Gram-negative bacteria (Shionogi/partner announcement).

✅ Oct 27, 2025 - IND / clinical progress (K-industry item): MicrobiotiX (Korea) received IND approval / progressed toward phage therapy clinical trial funding and Series B - signals growing Korean activity in alternative anti-infectives (bacteriophage therapies).

Europe (EU / UK / wider Europe) - Industry Latest News 2025

✅ 2025 (various dates) - Clinical development: Roche expanded/advanced trials of a promising antibiotic against highly resistant Acinetobacter (phase progression / larger global phase-3 planning announced in 2025). This is a major development for Gram-negative antibiotic candidates.

✅ Sep 23, 2025 - EU policy/partnership (regional AMR program): European Commission launched a One Health AMR Partnership (OHAMR) with large funding to boost AMR research & innovation (multi-year EU programme).

✅ Sep 22-23, 2025 - Asset M&A: EMV Capital (and related buyers) acquired certain assets from Destiny Pharma (including the XF-73 program)-an example of consolidation / asset buys in European AMR space.

Growth Forecast Projected:

The Global Antibiotics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Antibiotics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=antibiotics-market?sg

Key Segments:

By Spectrum(Broad-spectrum antibiotics, Narrow-spectrum antibiotics)

By Drug Class(β-lactams, Macrolides, Fluoroquinolones, Aminoglycosides, Tetracyclines, Glycopeptides, Sulphonamides and Others)

By Route of Administration(Oral, Injectable, Others)

By Distribution Channel(Hospital Pharmacies, Retail pharmacies, Online pharmacies)

Regions Covered(North America, Europe, Asia-Pacific, South America and the Middle East & Africa).

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Antibiotics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Antibiotics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/antibiotics-market?sg

FAQ's

Q1: What is the current size of the Antibiotics Market?

A: The Antibiotics Market stood at US$ 41.54Billion in 2024 and is set to experience remarkable growth, reaching US$ 55.26Billion by 2033

Q2: How fast is the Antibiotics Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 3.20% from 2025-2033

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/antibiotics-market?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.